Nanobiotix NBTX
$26.50 −$0.82 (-2.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.50 0.00%
Open$28.15
Prev close$27.32
Day range$26.12 – $28.60
Volume125.3K
Market cap$1.35B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: ANNUAL, ended Dec 2025 · reported in EUR
Revenue€29.64M+355.3% YoY
Operating profit-€10.82M+84.2% YoY
Net profit-€23.96M+64.8% YoY
Diluted EPS-€0.50+65.3% YoY
Annual revenue
Profitability & balance sheet
Operating margin-353.6%
Net margin-632.5%
Return on assets-60.9%
Current ratio1.44
Liabilities / assets126.0%
Cash & investments€110.89M
Total debt€105.38M
Net cash (debt)€5.51M
Where the revenue comes from
Quarter 2025/FY
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Balance sheet
| Line item | 2026 Q2 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q2 (EUR) |
2024 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Total Assets | €128.33M | €67.76M | €67.76M | €45.17M | €67.42M |
| Total Current Assets | €123.48M | €62.75M | €62.75M | €39.89M | €61.47M |
| Cash and Cash Equivalents & Short-Term Investments | €110.89M | €52.75M | €52.75M | €28.82M | €49.74M |
| -Cash and Cash Equivalents | €110.89M | €52.75M | €52.75M | €28.82M | €49.74M |
| Receivables | €9.37M | €7.68M | €7.68M | €9.15M | €8.54M |
| -Accounts Receivable | €1.93M | €2.14M | €2.14M | €1.84M | €2.98M |
| -Taxes Receivable | €6.22M | €4.12M | €4.12M | €5.98M | €4.47M |
| -Other Receivables | €1.22M | €1.43M | €1.43M | €1.33M | €1.09M |
| Prepaid Assets | €3.22M | €2.32M | €2.32M | €1.93M | €3.20M |
| Total Non-Current Assets | €4.85M | €5.01M | €5.01M | €5.28M | €5.95M |
| Net PPE | €4.41M | €4.57M | €4.57M | €4.86M | €5.54M |
| -Gross PPE | €17.64M | €17.01M | €17.01M | €16.50M | €16.56M |
| -Accumulated Depreciation | -€13.23M | -€12.44M | -€12.44M | -€11.64M | -€11.02M |
| Non-Current Prepaid Assets | €409,000.00 | €409,000.00 | €409,000.00 | €409,000.00 | €406,000.00 |
| Goodwill and Other Intangible Assets | €7,000.00 | €10,000.00 | €10,000.00 | €13,000.00 | €7,000.00 |
| -Other Intangible Assets | €7,000.00 | €10,000.00 | €10,000.00 | €13,000.00 | €7,000.00 |
| Other Non-Current Assets | €25,000.00 | €25,000.00 | €25,000.00 | -€1,000.00 | – |
| Total Liabilities | €161.71M | €152.24M | €152.24M | €114.13M | €133.12M |
| Total Current Liabilities | €85.93M | €57.51M | €57.51M | €63.04M | €58.94M |
| Payables | €11.73M | €14.01M | €14.01M | €11.23M | €12.03M |
| -Accounts Payable | €6.16M | €6.58M | €6.58M | €4.23M | €4.48M |
| -Total Tax Payable | €5.39M | €6.82M | €6.82M | €6.29M | €6.87M |
| -Other Payable | €179,000.00 | €613,000.00 | €613,000.00 | €714,000.00 | €672,000.00 |
| Current Accrued Expenses | €2.61M | €2.54M | €2.54M | €7.41M | €15.55M |
| Short-Term Debt and Capital Lease Obligation | €32.07M | €4.31M | €4.31M | €4.74M | €4.92M |
| -Current Debt | €30.83M | €3.10M | €3.10M | €3.49M | €3.66M |
| -Current Capital Lease Obligation | €1.23M | €1.21M | €1.21M | €1.25M | €1.26M |
| Current Provisions | €60,000.00 | €118,000.00 | €118,000.00 | €167,000.00 | €438,000.00 |
| Current Deferred Liabilities | €36.17M | €36.22M | €36.22M | €36.22M | €18.16M |
| Other Current Liabilities | €3.30M | €312,000.00 | €312,000.00 | €3.27M | €7.84M |
| Total Non-Current Liabilities | €75.78M | €94.74M | €94.74M | €51.09M | €74.19M |
| Long Term Debt and Capital Lease Obligation | €74.55M | €91.01M | €91.01M | €46.51M | €45.98M |
| -Long Term Debt | €73.28M | €89.12M | €89.12M | €44.12M | €43.01M |
| -Long Term Capital Lease Obligation | €1.27M | €1.89M | €1.89M | €2.39M | €2.97M |
| Employee Benefits | €556,000.00 | €507,000.00 | €507,000.00 | €479,000.00 | €432,000.00 |
| Other Non-Current Liabilities | €678,000.00 | €3.22M | €3.22M | €4.11M | €27.78M |
| Total Equity | -€33.38M | -€84.48M | -€84.48M | -€68.95M | -€65.70M |
| Stockholders' Equity | -€33.38M | -€84.48M | -€84.48M | -€68.95M | -€65.70M |
| Capital Stock | €1.53M | €1.45M | €1.45M | €1.45M | €1.42M |
| -Common Stock | €1.53M | €1.45M | €1.45M | €1.45M | €1.42M |
| Additional Paid-In Capital | €396.87M | €314.40M | €314.40M | €312.74M | €312.74M |
| Retained Earnings | -€34.29M | -€23.96M | -€23.96M | -€5.38M | -€68.13M |
| Less: Treasury Stock | -€228,000.00 | -€228,000.00 | -€228,000.00 | -€228,000.00 | -€228,000.00 |
| Gains/Losses Not Affecting Retained Earnings | -€397.26M | -€376.15M | -€376.15M | -€377.53M | -€311.51M |
| Other Current Assets | – | €2,000.00 | €2,000.00 | – | -€1,000.00 |
Income statement
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
2023 ANNUAL (EUR) |
2022 ANNUAL (EUR) |
2021 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €29.64M | -€11.61M | €30.06M | €0.00 | €2.65M |
| Total Operating Revenue | €29.64M | -€11.61M | €30.06M | €0.00 | €10,000.00 |
| Operating Expense | €40.46M | €56.78M | €56.84M | €46.70M | €52.59M |
| Selling and Admin Expenses | €20.22M | €20.06M | €21.66M | €17.48M | €19.02M |
| -General & Admin Expense | €20.22M | €20.06M | €21.66M | €17.48M | €19.02M |
| Research & Development | €23.12M | €40.54M | €38.40M | €32.64M | €30.38M |
| Depreciation & Amortization & Depletion | €345,000.00 | €319,000.00 | €270,000.00 | €335,000.00 | €416,000.00 |
| -Depreciation & Amortization | €345,000.00 | €319,000.00 | €270,000.00 | €335,000.00 | €416,000.00 |
| Other Taxes | -€2.82M | -€3.30M | -€3.94M | -€4.09M | -€2.49M |
| Other Operating Expenses | -€404,000.00 | -€837,000.00 | €448,000.00 | €343,000.00 | €5.27M |
| Operating Profit | -€10.82M | -€68.39M | -€26.78M | -€46.70M | -€52.58M |
| Net Non-Operating Interest Income (Expense) | -€9.91M | -€2.63M | -€6.48M | -€12.44M | -€658,000.00 |
| Non-Operating Interest Income | €985,000.00 | €2.63M | €1.22M | €256,000.00 | €0.00 |
| Non-Operating Interest Expense | €10.40M | €8.09M | €7.98M | €5.84M | €671,000.00 |
| Total Other Finance Costs | €496,000.00 | -€2.83M | -€285,000.00 | €6.86M | -€13,000.00 |
| Other Income (Expense) | -€3.23M | €2.99M | -€6.32M | €2.11M | €6.24M |
| Gain on Sale of Security | -€3.23M | €2.99M | -€6.32M | €2.11M | €6.24M |
| Pretax Profit | -€23.96M | -€68.03M | -€39.58M | -€57.03M | -€47.00M |
| Tax | €3,000.00 | €101,000.00 | €120,000.00 | €10,000.00 | €5,000.00 |
| Net Profit | -€23.96M | -€68.13M | -€39.70M | -€57.04M | -€47.00M |
| Profit from Continuing Operations | -€23.96M | -€68.13M | -€39.70M | -€57.04M | -€47.00M |
| Net Income to Parent Company | -€23.96M | -€68.13M | -€39.70M | -€57.04M | -€47.00M |
| Net Income to Common Stockholders | -€23.96M | -€68.13M | -€39.70M | -€57.04M | -€47.00M |
| Basic EPS | -€0.50 | -€1.44 | -€1.08 | -€1.64 | -€1.35 |
| Diluted EPS | -€0.50 | -€1.44 | -€1.08 | -€1.64 | -€1.35 |
| Special Income (Charges) | – | – | – | – | €0.00 |
Cash flow
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
2023 ANNUAL (EUR) |
2022 ANNUAL (EUR) |
2021 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | -€33.42M | -€19.55M | -€12.48M | -€37.10M | -€29.87M |
| Net cash flow from continuing operations | -€33.42M | -€19.55M | -€12.48M | -€37.11M | -€29.87M |
| Net Income from Continuing Operations | -€23.96M | -€68.13M | -€39.70M | -€57.04M | -€47.00M |
| Gain/Loss from Continuing Operations | €153,000.00 | -€3,000.00 | -€24,000.00 | €3,000.00 | – |
| Depreciation & Depletion & Amortization | €1.50M | €1.62M | €1.51M | €1.50M | €1.56M |
| Deferred Tax | €3,000.00 | €101,000.00 | €120,000.00 | €0.00 | €0.00 |
| Other Non-Cash Items | -€10.83M | €28.61M | €11.97M | €12.66M | €678,000.00 |
| Change in Working Capital | -€3.40M | €14.28M | €9.92M | €2.30M | €11.54M |
| -Change in Receivables | €1.85M | €355,000.00 | -€1.09M | -€1.83M | -€3.05M |
| -Change in Payables and Accrued Expense | -€5.41M | €1.96M | €8.68M | €2.91M | -€281,000.00 |
| -Change in Other Current Liabilities | €175,000.00 | -€224,000.00 | €723,000.00 | €1.22M | -€1.65M |
| -Change In Other Working Capital | -€16,000.00 | €12.19M | €1.61M | – | €16.52M |
| Net cash flow from investing | -€578,000.00 | -€955,000.00 | -€349,000.00 | €138,000.00 | -€242,000.00 |
| Net Cash Flow from Continuing Investing Activities | -€578,000.00 | -€955,000.00 | -€349,000.00 | €137,000.00 | -€242,000.00 |
| Net PPE Purchase and Sale | -€538,000.00 | -€846,000.00 | -€328,000.00 | -€92,000.00 | -€228,000.00 |
| Net Intangibles Purchase and Sale | -€8,000.00 | -€2,000.00 | -€9,000.00 | -€1,000.00 | -€5,000.00 |
| Net Investment Purchase and Sale | -€32,000.00 | -€107,000.00 | -€12,000.00 | €230,000.00 | -€9,000.00 |
| Financing Cash Flow | €37.42M | -€5.14M | €46.77M | -€5.65M | -€5.18M |
| Net Cash Flow from Continuing Financing Activities | €37.42M | -€5.14M | €46.77M | -€5.65M | -€5.18M |
| Net Issuance Payments Of Debt | €38.19M | -€4.16M | -€3.62M | -€4.74M | -€3.74M |
| Net Common Stock Issuance | €1.54M | €0.00 | €60.15M | €0.00 | €0.00 |
| Cash Dividends Paid | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Net Other Financing Charges | -€778,000.00 | – | -€2.79M | -€1,000.00 | -€349,000.00 |
| Ending Cash Balance | €52.75M | €49.74M | €75.28M | €41.39M | €83.92M |
| Net Change in Cash | €3.42M | -€25.64M | €33.95M | -€42.62M | -€35.29M |
| Beginning Cash Balance | €49.74M | €75.28M | €41.39M | €83.92M | €119.15M |
| Effect of Exchange Rate Changes | -€402,000.00 | €94,000.00 | -€51,000.00 | €83,000.00 | €64,000.00 |
| Free Cash Flow | -€33.97M | -€20.40M | -€12.81M | -€37.20M | -€30.11M |
| Net Other Investing Changes | – | – | – | €1,000.00 | – |
| Proceeds from Stock Option Exercised | – | – | – | – | €43,000.00 |
No comments yet — be the first to weigh in on NBTX.
Sign in to join the discussion.